Dr. Shailesh R. Satpute
Claim this profileBaptist Memorial Hospital and Cancer Center-Desoto
Studies Small Cell Lung Cancer
Studies Small Cell Carcinoma
5 reported clinical trials
15 drugs studied
Area of expertise
1Small Cell Lung Cancer
Stage IV
Stage I
Stage II
2Small Cell Carcinoma
Stage IV
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Shailesh R. Satpute is currently running
Chemotherapy + Bevacizumab + Atezolizumab
for Colorectal Cancer
This phase III trial studies how well combination chemotherapy, bevacizumab, and/or atezolizumab work in treating patients with deficient deoxyribonucleic acid (DNA) mismatch repair colorectal cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as fluorouracil, oxaliplatin, and leucovorin calcium, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Bevacizumab may stop or slow colorectal cancer by blocking the growth of new blood vessels necessary for tumor growth. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving combination chemotherapy, bevacizumab, and atezolizumab may work better in treating patients with colorectal cancer.
Recruiting2 awards Phase 31 criteria
Chemotherapy vs Radioactive Drug
for Pancreatic Neuroendocrine Tumors
This phase II trial compares capecitabine and temozolomide to lutetium Lu 177 dotatate for the treatment of pancreatic neuroendocrine tumors that have spread to other parts of the body (advanced) or are not able to be removed by surgery (unresectable). Chemotherapy drugs, such as capecitabine and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radioactive drugs, such as lutetium Lu 177 dotatate, may carry radiation directly to tumor cells and may reduce harm to normal cells. The purpose of this study is to find out whether capecitabine and temozolomide or lutetium Lu 177 dotatate may kill more tumor cells in patients with advanced pancreatic neuroendocrine tumors.
Recruiting3 awards Phase 224 criteria
More about Shailesh R. Satpute
Clinical Trial Related6 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Shailesh R. Satpute has experience with
- Atezolizumab
- Prophylactic Cranial Irradiation
- Magnetic Resonance Imaging
- Abiraterone Acetate
- Cabazitaxel
- Antiandrogen Therapy
Breakdown of trials Shailesh R. Satpute has run
Small Cell Lung Cancer
Small Cell Carcinoma
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Shailesh R. Satpute specialize in?
Shailesh R. Satpute focuses on Small Cell Lung Cancer and Small Cell Carcinoma. In particular, much of their work with Small Cell Lung Cancer has involved Stage IV patients, or patients who are Stage I.
Is Shailesh R. Satpute currently recruiting for clinical trials?
Yes, Shailesh R. Satpute is currently recruiting for 4 clinical trials in Southhaven Mississippi. If you're interested in participating, you should apply.
Are there any treatments that Shailesh R. Satpute has studied deeply?
Yes, Shailesh R. Satpute has studied treatments such as Atezolizumab, Prophylactic Cranial Irradiation, Magnetic Resonance Imaging.
What is the best way to schedule an appointment with Shailesh R. Satpute?
Apply for one of the trials that Shailesh R. Satpute is conducting.
What is the office address of Shailesh R. Satpute?
The office of Shailesh R. Satpute is located at: Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven, Mississippi 38671 United States. This is the address for their practice at the Baptist Memorial Hospital and Cancer Center-Desoto.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.